Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …
updated evidence-based strategy for asthma management and prevention, which can be …
Improving lung health in low-income and middle-income countries: from challenges to solutions
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …
Advances and highlights in asthma in 2021
Last year brought a significant advance in asthma management, unyielding to the pressure
of the pandemics. Novel key findings in asthma pathogenesis focus on the resident cell …
of the pandemics. Novel key findings in asthma pathogenesis focus on the resident cell …
As-needed budesonide–formoterol versus maintenance budesonide in mild asthma
Background Patients with mild asthma often rely on inhaled short-acting β2-agonists for
symptom relief and have poor adherence to maintenance therapy. Another approach might …
symptom relief and have poor adherence to maintenance therapy. Another approach might …
[HTML][HTML] GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults …
In April 2019, the Global Initiative for Asthma (GINA)(box 1) published new
recommendations that might be considered the most fundamental change in asthma …
recommendations that might be considered the most fundamental change in asthma …
Asthma management in low and middle income countries: case for change
Asthma is the most common noncommunicable disease in children, and among the most
common in adults. The great majority of people with asthma live in low and middle income …
common in adults. The great majority of people with asthma live in low and middle income …
The global initiative for asthma (GINA): 25 years later
The Global Initiative for Asthma (GINA) was launched in 1993 under the auspices of the
National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World …
National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World …
Controlled trial of budesonide–formoterol as needed for mild asthma
Background In double-blind, placebo-controlled trials, budesonide–formoterol used on an
as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed …
as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed …
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52 …
Background In adults with mild asthma, a combination of an inhaled corticosteroid with a fast-
onset long-acting β-agonist (LABA) used as reliever monotherapy reduces severe …
onset long-acting β-agonist (LABA) used as reliever monotherapy reduces severe …